375 related articles for article (PubMed ID: 26728869)
21. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
[TBL] [Abstract][Full Text] [Related]
22. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
23. Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma.
Devarajan B; Prakash L; Kannan TR; Abraham AA; Kim U; Muthukkaruppan V; Vanniarajan A
BMC Cancer; 2015 Apr; 15():320. PubMed ID: 25928201
[TBL] [Abstract][Full Text] [Related]
24. SeqCNV: a novel method for identification of copy number variations in targeted next-generation sequencing data.
Chen Y; Zhao L; Wang Y; Cao M; Gelowani V; Xu M; Agrawal SA; Li Y; Daiger SP; Gibbs R; Wang F; Chen R
BMC Bioinformatics; 2017 Mar; 18(1):147. PubMed ID: 28253855
[TBL] [Abstract][Full Text] [Related]
25. Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA.
Yang X; Chu Y; Zhang R; Han Y; Zhang L; Fu Y; Li D; Peng R; Li D; Ding J; Li Z; Zhao M; Zhang K; Lu T; Yi L; Wu Q; Lin G; Xie J; Liu T; Yang L; Yi X; Li J
J Mol Diagn; 2017 Jul; 19(4):525-536. PubMed ID: 28502728
[TBL] [Abstract][Full Text] [Related]
26. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
27. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
Povysil G; Tzika A; Vogt J; Haunschmid V; Messiaen L; Zschocke J; Klambauer G; Hochreiter S; Wimmer K
Hum Mutat; 2017 Jul; 38(7):889-897. PubMed ID: 28449315
[TBL] [Abstract][Full Text] [Related]
28. CNV Radar: an improved method for somatic copy number alteration characterization in oncology.
Soong D; Stratford J; Avet-Loiseau H; Bahlis N; Davies F; Dispenzieri A; Sasser AK; Schecter JM; Qi M; Brown C; Jones W; Keats JJ; Auclair D; Chiu C; Powers J; Schaffer M
BMC Bioinformatics; 2020 Mar; 21(1):98. PubMed ID: 32143562
[TBL] [Abstract][Full Text] [Related]
29. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
Rosenthal SH; Gerasimova A; Ma C; Li HR; Grupe A; Chong H; Acab A; Smolgovsky A; Owen R; Elzinga C; Chen R; Sugganth D; Freitas T; Graham J; Champion K; Bhattacharya A; Racke F; Lacbawan F
PLoS One; 2021; 16(4):e0243683. PubMed ID: 33909614
[TBL] [Abstract][Full Text] [Related]
30. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
[No Abstract] [Full Text] [Related]
31. Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants.
Cacheiro P; Ordóñez-Ugalde A; Quintáns B; Piñeiro-Hermida S; Amigo J; García-Murias M; Pascual-Pascual SI; Grandas F; Arpa J; Carracedo A; Sobrido MJ
Mol Diagn Ther; 2017 Jun; 21(3):303-313. PubMed ID: 28290094
[TBL] [Abstract][Full Text] [Related]
32. Detection of CNVs in NGS Data Using VS-CNV.
Fortier N; Rudy G; Scherer A
Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
[TBL] [Abstract][Full Text] [Related]
33. Modeling the next generation sequencing read count data for DNA copy number variant study.
Ji T; Chen J
Stat Appl Genet Mol Biol; 2015 Aug; 14(4):361-74. PubMed ID: 26140731
[TBL] [Abstract][Full Text] [Related]
34. Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling.
McNulty SN; Cottrell CE; Vigh-Conrad KA; Carter JH; Heusel JW; Ansstas G; Dahiya S
Hum Pathol; 2019 Apr; 86():170-181. PubMed ID: 30594748
[TBL] [Abstract][Full Text] [Related]
35. Simplifying Detection of Copy-Number Variations in Maturity-Onset Diabetes of the Young.
Berberich AJ; Wang J; Cao H; McIntyre AD; Spaic T; Miller DB; Stock S; Huot C; Stein R; Knoll J; Yang P; Robinson JF; Hegele RA
Can J Diabetes; 2021 Feb; 45(1):71-77. PubMed ID: 33011132
[TBL] [Abstract][Full Text] [Related]
36. Validation of copy number variation analysis for next-generation sequencing diagnostics.
Ellingford JM; Campbell C; Barton S; Bhaskar S; Gupta S; Taylor RL; Sergouniotis PI; Horn B; Lamb JA; Michaelides M; Webster AR; Newman WG; Panda B; Ramsden SC; Black GC
Eur J Hum Genet; 2017 Jun; 25(6):719-724. PubMed ID: 28378820
[TBL] [Abstract][Full Text] [Related]
37. Copy Number Variation in GCK in Patients With Maturity-Onset Diabetes of the Young.
Berberich AJ; Huot C; Cao H; McIntyre AD; Robinson JF; Wang J; Hegele RA
J Clin Endocrinol Metab; 2019 Aug; 104(8):3428-3436. PubMed ID: 30912798
[TBL] [Abstract][Full Text] [Related]
38. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
Lee PJ; Yoo NS; Hagemann IS; Pfeifer JD; Cottrell CE; Abel HJ; Duncavage EJ
Exp Mol Pathol; 2017 Feb; 102(1):156-161. PubMed ID: 28093192
[TBL] [Abstract][Full Text] [Related]
40. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
